Related references
Note: Only part of the references are listed.High-fat diet-induced colonocyte dysfunction escalates microbiota-derived trimethylamine N-oxide
Woongjae Yoo et al.
SCIENCE (2021)
Trimethylamine N-oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction
Xiang Zhou et al.
ESC HEART FAILURE (2020)
3,3-Dimethyl-1-butanol attenuates cardiac remodeling in pressure-overload-induced heart failure mice
Guangji Wang et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2020)
Gut microbiota-derived trimethylamineN-oxide is associated with poor prognosis in patients with heart failure
Wensheng Li et al.
MEDICAL JOURNAL OF AUSTRALIA (2020)
Trimethylamine N-Oxide Was Not Associated With 30-Day Left Ventricular Systolic Dysfunction in Patients With a First Anterior ST-Segment Elevation Myocardial Infarction After Primary Revascularization: A Sub-analysis From an Optical Coherence Tomography Registry
Jinying Zhou et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Gut microbe-derived metabolite trimethylamine N-oxide induces cardiac hypertrophy and fibrosis
Zehua Li et al.
LABORATORY INVESTIGATION (2019)
Gut microbe-derived metabolite trimethylamine N-oxide accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis
Wenlong Yang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)
Trimethylamine N-Oxide Exacerbates Cardiac Fibrosis via Activating the NLRP3 Inflammasome
Xueling Li et al.
FRONTIERS IN PHYSIOLOGY (2019)
Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012-2015
Guang Hao et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Trimethylamine N-oxide and incident atherosclerotic events in high-risk individuals with diabetes: an ACCORD trial post hoc analysis
Andrea Cardona et al.
BMJ OPEN DIABETES RESEARCH & CARE (2019)
Guggulsterone, a farnesoid X receptor antagonist lowers plasma trimethylamine-N-oxide levels: An evidence from in vitro and in vivo studies
A. Gautam et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2019)
Enalapril decreases rat plasma concentration of TMAO, a gut bacteria-derived cardiovascular marker
Marek Konop et al.
BIOMARKERS (2018)
Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk
W. Zhu et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
High salt intake increases plasma trimethylamine N-oxide (TMAO) concentration and produces gut dysbiosis in rats
Klaudia Bielinska et al.
NUTRITION (2018)
Lactobacillus plantarum ZDY04 exhibits a strain-specific property of lowering TMAO via the modulation of gut microbiota in mice
Liang Qiu et al.
FOOD & FUNCTION (2018)
Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients
Xiao Cui et al.
SCIENTIFIC REPORTS (2018)
Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential
Adam B. Roberts et al.
NATURE MEDICINE (2018)
Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis
Gabriele Giacomo Schiattarella et al.
EUROPEAN HEART JOURNAL (2017)
Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria
Marina Makrecka-Kuka et al.
TOXICOLOGY LETTERS (2017)
Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies
Yoriko Heianza et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Trimethylamine-N-Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3-SOD2-mtROS Signaling Pathway
Ming-liang Chen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide Contributes to Cardiac Dysfunction in Western Diet-Induced Obese Mice
Kui Chen et al.
FRONTIERS IN PHYSIOLOGY (2017)
Elevated Circulating Trimethylamine N-Oxide Levels Contribute to Endothelial Dysfunction in Aged Rats through Vascular Inflammation and Oxidative Stress
Tiejun Li et al.
FRONTIERS IN PHYSIOLOGY (2017)
Novel Concept of a Heart-Gut Axis in the Pathophysiology of Heart Failure
Takehiro Kamo et al.
KOREAN CIRCULATION JOURNAL (2017)
Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure
Takehiro Kamo et al.
PLOS ONE (2017)
Heart failure is associated with depletion of core intestinal microbiota
Mark Luedde et al.
ESC HEART FAILURE (2017)
Enterobacter aerogenes ZDY01 Attenuates Choline-Induced Trimethylamine N-Oxide Levels by Remodeling Gut Microbiota in Mice
Liang Qiu et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2017)
Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure
Chelsea L. Organ et al.
CIRCULATION-HEART FAILURE (2016)
High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome
Francesca De Filippis et al.
GUT (2016)
Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-κB
Marcus M. Seldin et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Pathogenic Gut Flora in Patients With Chronic Heart Failure
Evasio Pasini et al.
JACC-HEART FAILURE (2016)
Probiotic therapy with Saccharomyces boulardii for heart failure patients: A randomized, double-blind, placebo-controlled pilot trial
Annelise C. Costanza et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis
Yuji Nagatomo et al.
JOURNAL OF CARDIAC FAILURE (2015)
Intestinal Microbiota-Dependent Phosphatidylcholine Metabolites, Diastolic Dysfunction, and Adverse Clinical Outcomes in Chronic Systolic Heart Failure
W. H. Wilson Tang et al.
JOURNAL OF CARDIAC FAILURE (2015)
Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure
M. Troseid et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart Failure Refining the Gut Hypothesis
W. H. Wilson Tang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Intestinal Blood Flow in Patients With Chronic Heart Failure A Link With Bacterial Growth, Gastrointestinal Symptoms, and Cachexia
Anja Sandek et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary Regulation
Brian J. Bennett et al.
CELL METABOLISM (2013)
EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)
Aldo P. Maggioni et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Intestinal microbiota determine severity of myocardial infarction in rats
Vy Lam et al.
FASEB JOURNAL (2012)
Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure
Anja Sandek et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
Heart failure incidence and survival (from the atherosclerosis risk in communities study)
Laura R. Loehr et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Altered intestinal function in patients with chronic heart failure
Anja Sandek et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Role of bacterial endotoxin in chronic heart failure: The gut of the matter
Bambos M. Charalambous et al.
SHOCK (2007)
Selective intestinal decontamination in advanced chronic heart failure: a pilot trial
VM Conraads et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
More 'malignant' than cancer? Five-year survival following a first admission for heart failure
S Stewart et al.
EUROPEAN JOURNAL OF HEART FAILURE (2001)
Share Paper
